GCI Europe 2019
GCI Europe 2019

GCI Europe 2019

November 13-14, 2019

The ultimate networking community for global leaders focused on European cannabis

Brochure downloadBrochure download

* Required fields
Here at the Global Cannabis Institute we take your privacy seriously and will only use your personal information to provide you with the expected advantages of our services and functionalities. By clicking "SEND" you agree that we store your data.

ABOUT US

GCI Europe brings together leaders, like you, at the forefront of cannabis. Our unique format enables you to customise an agenda, specific to your needs - you’ll be able to network with and learn from medical professionals, strategic business leaders, service providers and investors alike.
The home of networking for innovators at the heart of health and wellness within the European Cannabis Market
Across our two knowledge sharing summits, you’ll be able to learn about world-first medical breakthroughs, uncover the most successful consumer product strategies, and explore the tech and services that will underpin our industry’s progression.

Meeting the people behind the companies is crucial - you’ll not only connect with business leaders important to your working life, but will make lasting relations with like-minded friends from across the industry. To ensure this, we’ve woven in ample networking opportunities and interactive breakout streams throughout the two days, so you’ll be able to solidify relationships with the pioneers driving innovations forward.

 




At GCI Europe 2019, we’ll be hosting two co-located knowledge
sharing summits for you

 
Disruptive forces are changing the world as we know it for the better, presenting a plethora of opportunities for innovators who like to push the boundaries. Of course, the European cannabis infrastructure is still developing, and as such, provides a multitude of cross-border regulatory challenges that we’re all facing daily. But with challenges, come opportunities.
 



The Future of Medical Cannabis and Cannabis Derived Treatment:


Bringing together the greatest minds in the space, doctors, academics, and researchers from across the continent will share exclusive insights and groundbreaking developments with peers all focused on the same goal - enhancing and saving lives with cannabis derived treatment.

 



Winning Business Strategies for Consumer Products:


Opportunity favours the brave, and with appetite for cannabis derived consumer products at an all time high (no pun intended), the landscape for nutraceutical, food, beverages, skincare, and petcare goods increases rapidly. Learn how to navigate the regulatory minefield from your counterparts, meet new business partners, and refine your strategy to conquer the European markets.
 



Interactive Breakout Streams
 
Two Dedicated breakout streams focus on Key Canna Economies in Europe and Cannabis & Hemp Cultivation. Learn about the current and future regulatory, political, medical, investment and cultural landscape of 8 key countries (as told by expert Conversation Leaders from each region) and/or discover the best strategies to optimize your cultivation operation to service the European Markets.
 

WHY ATTEND?

At Winning Strategies for Consumer Products, you’ll:
Understand how to navigate the complex web of European regulations | Learn about cultural nuances in key countries and how that impacts marketing initiatives | Uncover winning strategies for product launches |
Discuss ways in which industry leaders can collectively lobby policy-makers | Meet like-minded leaders to develop relations, do business, and build strategic partnerships | Raise your profile as industry leaders in your segment of the market |
Gain exposure to investors and service providers who can take your business to the next level |
At <b>Winning Strategies for Consumer Products</b>, you’ll:
At Future of Medical Cannabis & Cannabis Derived Treatment, you’ll:
Collaborate with leading cannabis researchers and academics | Discover about the projects your European and North American counterparts are spearheading | Understand how to translate complex medical language into palatable language for wider public education |
Meet the people behind the industry’s finest tech | Hear from patients using and campaigning for medicinal cannabis and cannabis derived treatment | Raise your profile as a thought-leader within the medical cannabis community |
At <b>Future of Medical Cannabis & Cannabis Derived Treatment</b>, you’ll:

FIND OUT MOREFIND OUT MORE

* Required fields
Here at the Global Cannabis Institute we take your privacy seriously and will only use your personal information to provide you with the expected advantages of our services and functionalities. By clicking "SEND" you agree that we store your data.

Register today

Consumer brands*, clinicians, private investors,
university researchers, retail distributors, policy & government
31% Discount
Individual
Full price: £800
Super Early Bird: £550
44% Discount
Group (3 +)
Full price: £800
Super Early Bird: £450
Your Organization Not Listed Above?
Not to worry - please email us on enquiries@gc-institute.org to find out how you can join the community and attend GCI Europe.

GCI Partners

Gold Sponsor
Golders Hill
Silver Sponsor
CannaPowder
Bronze Sponsor
Advanced Dynamics
Event Partners
Brink's
LIO Pharmaceuticals
Media Partners
Copybook
Krautinvest
CBD-Intel
Cannabis Trades Association
Health Europe
Hemp Events
Infuzes
Dosage
https://canna-powder.com
The first cannabis activated nanometric powder derived from cannabis oil, making cannabis available to a broader market by increasing the number of delivery options for producers and consumers. The technology was developed at The Hebrew University of Jerusalem by Dr. Shlomo Magdassi, a world leader in R&amp;D of medical cannabis.
https://www.brinks.com/en/
The Brink’s Company (NYSE:BCO) is a global leader in high-value logistics, cash management and payments services. We deliver sophisticated, secure, tailored logistics and cash management services to the cannabis industry, from seed to sale, in select locations where the industry has been legalized. With operations in 40+ countries and 62,000 employees, we have a proven history of building customized supply chains for highly regulated and diverse industries, and a global network of expertise, infrastructure and certified partner programs.
https://www.liopharmaceuticals.com/en/home-en/
LIO Pharmaceuticals GmbH combines long-standing experience in the European pharmaceutical market with the vision of an innovative start-up company. 
Specialized in the import and distribution of high quality cannabis materials, LIO is committed to support the medical care and therefore improve the quality of life of patients. From Mission & Vision, through Product, to Market Access, all the way to Sales & Marketing, the Experience always meets innovation Spirit. 

As an interdisciplinary team led by founder and CEO Alain Menghé à Menghé, LIO Pharmaceuticals relies both internally and externally on modern corporate communications, flat hierarchies and an open work environment. 

LIO Pharmaceuticals...Experience driven, Patient focus.
Global Cannabis Institute
X
Privacy policy and how we use cookies
We use cookies to give you the best experience on our website.
By continuing we'll assume you're on board with our privacy policy
Accept and hide this message